Evidence map›Paper›PMID 36532428›Full record

ArticleFrontiers in microbiology2022

Takeshi Sekiya, Yukino Ogura, Hirayasu Kai, Atsushi Kawaguchi, Shino Okawa, Mikako Hirohama, Takahiro Kuroki, Wataru Morii, Akira Hara, Yuji Hiramatsu and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Takeshi SekiyaDepartment of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yukino OguraDepartment of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hirayasu KaiDepartment of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Atsushi KawaguchiDepartment of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Shino OkawaCollege of Biological Sciences, University of Tsukuba, Tsukuba, Japan.
Mikako HirohamaDepartment of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takahiro KurokiGraduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
Wataru MoriiGraduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
Akira HaraDepartment of Otorhinolaryngology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yuji HiramatsuDepartment of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Shigemi HitomiDepartment of Infectious Diseases, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yasushi KawakamiDepartment of Laboratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yoshihiro ArakawaDepartment of Medical Pharmacy, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kazushi MaruoDepartment of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Shigeru ChibaDepartment of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hiromichi SuzukiDepartment of Infectious Diseases, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hiroshi KojimaIbaraki Clinical Education and Training Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hirokazu TachikawaDivision of Clinical Medicine, Department of Disaster and Community Psychiatry, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kunihiro YamagataDepartment of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
University of Tsukuba · JPTsukuba Medical Center Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has a wide range of clinical presentations, and the susceptibility to SARS-CoV-2 infection and the mortality rate also vary by region and ethnicity. Here, we found that rs12329760 in the

Indexed as

COVID-19SARS-CoV-2SNPtmprss2virus entry

Identifiers

PMID36532428
PMCPMC9748344
OpenAlexW4310807731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.